Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review.
暂无分享,去创建一个
M. Muiesan | P. Mulatero | S. Monticone | J. Lenders | R. Kreutz | A. Januszewicz | P. Sarafidis | E. Rexhaj | E. Agabiti-Rosei | G. Eisenhofer | M. Reincke | A. Kasiakogias | P. Van der Niepen | P. Dobrowolski | R. Soria | A. Prejbisz | F. Messerli | A. Persu | M. Śpiewak | M. Januszewicz | P. van der Niepen
[1] M. Tetti,et al. Aldosterone as a Mediator of Cardiovascular Damage. , 2022, Hypertension.
[2] E. Boerwinkle,et al. Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study , 2022, Hypertension.
[3] M. Reincke,et al. Long‐term morbidity and mortality in patients with Cushing's syndrome , 2022, Journal of neuroendocrinology.
[4] S. Carugo,et al. Effect of long-term antihypertensive therapy on myocardial strain: a meta-analysis , 2022, Journal of hypertension.
[5] A. Tabarin,et al. Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors , 2022, Annals of Internal Medicine.
[6] R. Vasan,et al. Hypertension-Mediated Organ Damage: Prevalence, Correlates, and Prognosis in the Community , 2021, Hypertension.
[7] P. Pellikka,et al. Cardiac Remodeling and Disease Progression in Patients With Repaired Coarctation of Aorta and Aortic Stenosis , 2021, Circulation. Cardiovascular imaging.
[8] R. D. de Winter,et al. Cardiovascular Morbidity and Mortality in Adult Patients With Repaired Aortic Coarctation , 2021, Journal of the American Heart Association.
[9] G. Mancia,et al. Left ventricular global longitudinal strain in secondary hypertension: A meta-analysis of echocardiographic studies. , 2021, European journal of internal medicine.
[10] A. Egbe,et al. Prognostic implications of left heart diastolic dysfunction in adults with coarctation of aorta. , 2021, European heart journal. Cardiovascular Imaging.
[11] K. Johansen,et al. Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference , 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] L. Lerman,et al. Renal Revascularization Attenuates Myocardial Mitochondrial Damage and Improves Diastolic Function in Pigs with Metabolic Syndrome and Renovascular Hypertension , 2021, Journal of Cardiovascular Translational Research.
[13] A. Egbe,et al. Persistent Hypertension and Left Ventricular Hypertrophy After Repair of Native Coarctation of Aorta in Adults , 2021, Hypertension.
[14] S. Carugo,et al. Effect of surgical treatment on myocardial strain in patients with pheochromocytoma and paraganglioma: a mini-review and meta-analysis , 2021, Journal of Endocrinological Investigation.
[15] P. Dahlqvist,et al. Prevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease: a systematic review and meta-analysis , 2021, Pituitary.
[16] T. Zelinka,et al. Effect of adrenalectomy on remission of subclinical left ventricular dysfunction in patients with pheochromocytoma: a speckle-tracking echocardiography study , 2021, Endocrine connections.
[17] C. Zauner,et al. Acute and life-threatening complications in Cushing's syndrome: prevalence, predictors and mortality. , 2021, The Journal of clinical endocrinology and metabolism.
[18] Junting Hu,et al. Acute cardiac complications and subclinical myocardial injuries associated with pheochromocytoma and paraganglioma , 2020, BMC Cardiovascular Disorders.
[19] L. Lerman,et al. Renovascular hypertension induces myocardial mitochondrial damage, contributing to cardiac injury and dysfunction in pigs with metabolic syndrome. , 2020, American journal of hypertension.
[20] A. Egbe,et al. Predictors of left ventricular reverse remodelling after coarctation of aorta intervention. , 2020, European heart journal cardiovascular Imaging.
[21] A. Presson,et al. Implications of Left Ventricular Dysfunction at Presentation for Infants with Coarctation of the Aorta , 2020, Pediatric Cardiology.
[22] A. Cremer,et al. [Chronic pheochromocytoma-induced myocardial injuries: What should we expect from modern and classical echocardiographic tools?] , 2020, Annales de cardiologie et d'angeiologie.
[23] T. Bednarczuk,et al. Left Ventricular Structural and Functional Alterations in Patients With Pheochromocytoma/Paraganglioma Before and After Surgery. , 2020, JACC. Cardiovascular imaging.
[24] É. Mousseaux,et al. Aldosterone-Related Myocardial Extracellular Matrix Expansion in Hypertension in Humans: A Proof-of-Concept Study by Cardiac Magnetic Resonance. , 2020, JACC. Cardiovascular imaging.
[25] G. Mancia,et al. Left ventricular mass reduction and hypertrophy regression following renal artery revascularization: a meta-analysis , 2020, Journal of hypertension.
[26] G. Grassi,et al. Targeting subclinical organ damage in obstructive sleep apnea: a narrative review , 2020, Journal of Human Hypertension.
[27] H. Falhammar,et al. Cardiovascular Manifestations and Complications of Pheochromocytomas and Paragangliomas , 2020, Journal of clinical medicine.
[28] S. Zacharieva,et al. Global longitudinal strain as a marker for systolic function in patients with pheochromocytomas. , 2020, Endocrine-related cancer.
[29] M. Russo,et al. Cardiomyopathies and Adrenal Diseases , 2020, International journal of molecular sciences.
[30] K. Pacak,et al. Pathophysiology and Acute Management of Tachyarrhythmias in Pheochromocytoma: JACC Review Topic of the Week. , 2020, Journal of the American College of Cardiology.
[31] L. Sechi,et al. Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. , 2020, Journal of hypertension.
[32] A. Egbe,et al. Increased prevalence of left ventricular diastolic dysfunction in adults with repaired coarctation of aorta , 2020, International journal of cardiology. Heart & vasculature.
[33] T. Zelinka,et al. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on endocrine hypertension of the European society of hypertension. , 2020, Journal of hypertension.
[34] G. Mancia,et al. Obstructive sleep apnoea syndrome and left ventricular hypertrophy: a meta-analysis of echocardiographic studies. , 2020, Journal of hypertension.
[35] T. Fukuda,et al. Impact of percutaneous revascularization on left ventricular mass and its relationship to outcome in hypertensive patients with renal artery stenosis. , 2020, American journal of hypertension.
[36] M. Litwin,et al. Systematic and Multidisciplinary Evaluation of Fibromuscular Dysplasia Patients Reveals High Prevalence of Previously Undetected Fibromuscular Dysplasia Lesions and Affects Clinical Decisions , 2020, Hypertension.
[37] H. Falhammar,et al. Clinical features, complications, and outcomes of exogenous and endogenous catecholamine‐triggered Takotsubo syndrome: A systematic review and meta‐analysis of 156 published cases , 2020, Clinical cardiology.
[38] G. Mancia,et al. Obstructive sleep apnea and cardiac mechanics: how strain could help us? , 2020, Heart Failure Reviews.
[39] A. Egbe,et al. Determinants of Left Ventricular Diastolic Function and Exertional Symptoms in Adults With Coarctation of Aorta , 2020, Circulation. Heart failure.
[40] I. Bancos,et al. Cardiovascular risk and mortality in patients with active and treated hypercortisolism. , 2020, Gland surgery.
[41] L. Lerman,et al. Selective intrarenal delivery of mesenchymal stem cell-derived extracellular vesicles attenuates myocardial injury in experimental metabolic renovascular disease , 2020, Basic Research in Cardiology.
[42] A. Wagenmakers,et al. Decreased Aerobic Exercise Capacity After Long-Term Remission From Cushing Syndrome: Exploration of Mechanisms , 2019, The Journal of clinical endocrinology and metabolism.
[43] C. Hung,et al. Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score–Matching Follow‐Up Study With Tissue Doppler Imaging , 2019, Journal of the American Heart Association.
[44] M. Russo,et al. Primary aldosteronism-associated cardiomyopathy: Clinical-pathologic impact of aldosterone normalization. , 2019, International journal of cardiology.
[45] Yan Li,et al. Left atrial myocardial dysfunction in patients with primary aldosteronism as assessed by speckle-tracking echocardiography. , 2019, Journal of hypertension.
[46] H. Falhammar,et al. Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome , 2019, Endocrine.
[47] J. Kaski,et al. Takotsubo syndrome's pathophysiology: still a mystery? , 2019, European heart journal.
[48] I. Bryngelsson,et al. Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study. , 2019, The Journal of clinical endocrinology and metabolism.
[49] M. Aronovitz,et al. Distinct Phenotypes Induced by Three Degrees of Transverse Aortic Constriction in Mice , 2019, Scientific Reports.
[50] K. Omata,et al. 3T MRI evaluation of regional catecholamine-producing tumor-induced myocardial injury , 2019, Endocrine connections.
[51] T. Zelinka,et al. Catecholamines Induce Left Ventricular Subclinical Systolic Dysfunction: A Speckle-Tracking Echocardiography Study , 2019, Cancers.
[52] Aditya M. Sharma,et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia , 2019, Vascular medicine.
[53] S. McCartney,et al. Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing's Syndrome: A Systematic Meta-Analysis , 2019, Front. Endocrinol..
[54] Yan Li,et al. Speckle-Tracking Echocardiographic Layer-Specific Strain Analysis on Subclinical Left Ventricular Dysfunction in Patients With Primary Aldosteronism , 2018, American journal of hypertension.
[55] H. Köstler,et al. Increased myocardial sodium signal intensity in Conn’s syndrome detected by 23Na magnetic resonance imaging , 2018, European heart journal cardiovascular Imaging.
[56] F. Kober,et al. Cushing Syndrome Is Associated With Subclinical LV Dysfunction and Increased Epicardial Adipose Tissue. , 2018, Journal of the American College of Cardiology.
[57] F. Moeller,et al. Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review. , 2018, Journal of the American College of Cardiology.
[58] K. Pacak,et al. Catecholamine-Induced Cardiomyopathy in Pheochromocytoma: How to Manage a Rare Complication in a Rare Disease? , 2018, Hormone and Metabolic Research.
[59] G. Curhan,et al. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism , 2018, JAMA cardiology.
[60] A. Januszewicz,et al. Echocardiographic assessment of left ventricular morphology and function in patients with fibromuscular dysplasia: the ARCADIA-POL study , 2018, Journal of hypertension.
[61] Jeroen J. Bax,et al. International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management , 2018, European heart journal.
[62] Jeroen J. Bax,et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology , 2018, European heart journal.
[63] C. Zoccali,et al. Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term , 2018, Hypertension.
[64] G. Curhan,et al. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. , 2018, The lancet. Diabetes & endocrinology.
[65] Fiorenzo Gaita,et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. , 2018, The lancet. Diabetes & endocrinology.
[66] S. Albert,et al. Pheochromocytoma as a reversible cause of cardiomyopathy: Analysis and review of the literature. , 2017, International journal of cardiology.
[67] G. Mancia,et al. Renal artery stenosis and left ventricular hypertrophy: an updated review and meta-analysis of echocardiographic studies , 2017, Journal of Hypertension.
[68] F. Gao,et al. Cardiovascular phenotype in Smad3 deficient mice with renovascular hypertension , 2017, PloS one.
[69] C. Brizard,et al. Elevated sympathetic activity, endothelial dysfunction, and late hypertension after repair of coarctation of the aorta. , 2017, International journal of cardiology.
[70] G. Gielerak,et al. Cushing’s Disease: Subclinical Left Ventricular Systolic and Diastolic Dysfunction Revealed by Speckle Tracking Echocardiography and Tissue Doppler Imaging , 2017, Front. Endocrinol..
[71] A. Sarybaev,et al. Right Ventricular Remodeling and Dysfunction in Obstructive Sleep Apnea: A Systematic Review of the Literature and Meta-Analysis , 2017, Canadian respiratory journal.
[72] Allan Klein,et al. A Test in Context: Myocardial Strain Measured by Speckle-Tracking Echocardiography. , 2017, Journal of the American College of Cardiology.
[73] S. Tsagarakis,et al. Cardiac hypertrophy in Cushing’s syndrome: if not hypertension then what? , 2017, Endocrine.
[74] P. Rossignol,et al. Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not? , 2017, Current Hypertension Reports.
[75] T. Zelinka,et al. Long-Term Effect of Adrenalectomy on Cardiovascular Remodeling in Patients With Pheochromocytoma , 2016, The Journal of clinical endocrinology and metabolism.
[76] Y. Ishikawa,et al. Pathology and molecular mechanisms of coarctation of the aorta and its association with the ductus arteriosus , 2017, The Journal of Physiological Sciences.
[77] F. Veglio,et al. Left ventricular geometry and 24-h blood pressure profile in Cushing’s syndrome , 2017, Endocrine.
[78] A. Tabarin,et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. , 2016, European journal of endocrinology.
[79] Niki Karavitaki,et al. Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study. , 2016, The lancet. Diabetes & endocrinology.
[80] M. Robson,et al. Pheochromocytoma Is Characterized by Catecholamine-Mediated Myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction. , 2016, Journal of the American College of Cardiology.
[81] M. Rojas,et al. Effects of Restoration of Blood Flow on the Development of Aortic Atherosclerosis in ApoE−/− Mice With Unilateral Renal Artery Stenosis , 2016, Journal of the American Heart Association.
[82] A. Papagianni,et al. To intervene or not? A man with multidrug-resistant hypertension, endovascular abdominal aneurysm repair, bilateral renal artery stenosis and end-stage renal disease salvaged with renal artery stenting , 2016, Blood pressure.
[83] M. Russo,et al. Atrogin-1 Pathway Activation in Cushing Syndrome Cardiomyopathy. , 2016, Journal of the American College of Cardiology.
[84] K. Kuck,et al. Differential diagnosis of a fulminant myocarditis: the pheochromocytoma crisis , 2015, European heart journal. Acute cardiovascular care.
[85] J. Lusson,et al. Acute and Chronic Pheochromocytoma-Induced Cardiomyopathies: Different Prognoses? , 2015, Medicine.
[86] Martin Reincke,et al. Subclinical hypercortisolism: a state, a syndrome, or a disease? , 2015, European journal of endocrinology.
[87] P. Kalra,et al. Risks for mortality and renal replacement therapy in atherosclerotic renovascular disease compared with other causes of chronic kidney disease , 2015, Nephrology.
[88] M. Gadelha,et al. Adverse effects of glucocorticoids: coagulopathy. , 2015, European journal of endocrinology.
[89] L. Lerman,et al. Paradigm Shifts in Atherosclerotic Renovascular Disease: Where Are We Now? , 2015, Journal of the American Society of Nephrology : JASN.
[90] O. Dekkers,et al. Management of endocrine disease: Mortality remains increased in Cushing's disease despite biochemical remission: a systematic review and meta-analysis. , 2015, European journal of endocrinology.
[91] A. Januszewicz,et al. Determinants of concentric left ventricular hypertrophy in patients with resistant hypertension: RESIST-POL study , 2015, Hypertension Research.
[92] P. Śliwiński,et al. Factors associated with diastolic dysfunction in patients with resistant hypertension: resist-POL study. , 2015, American journal of hypertension.
[93] P. Kalra,et al. Revascularisation of renal artery stenosis as a therapy for heart failure: an observational cohort study , 2015, The Lancet.
[94] R. Topor-Madry,et al. Independent association of obstructive sleep apnea with left ventricular geometry and systolic function in resistant hypertension: the RESIST-POL study. , 2014, Sleep medicine.
[95] P. Chanson,et al. Cardiac Structure and Function in Cushing's Syndrome: A Cardiac Magnetic Resonance Imaging Study , 2014, The Journal of clinical endocrinology and metabolism.
[96] P. Gallego,et al. Pulmonary hypertension in young adults with repaired coarctation of the aorta: an unrecognised factor associated with premature mortality and heart failure. , 2014, International journal of cardiology.
[97] P. Kilner,et al. Prevalence and prognostic implication of restenosis or dilatation at the aortic coarctation repair site assessed by cardiovascular MRI in adult patients late after coarctation repair. , 2014, International journal of cardiology.
[98] R. Golfieri,et al. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. , 2014, The lancet. Diabetes & endocrinology.
[99] Ralph B D'Agostino,et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. , 2014, The New England journal of medicine.
[100] L. Lerman,et al. Cardiac function in renovascular hypertensive patients with and without renal dysfunction. , 2014, American journal of hypertension.
[101] F. Veglio,et al. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. , 2013, The Journal of clinical endocrinology and metabolism.
[102] P. Filardi,et al. Cardiovascular involvement in patients affected by acromegaly: an appraisal. , 2013, International journal of cardiology.
[103] P. Plouin,et al. Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study , 2013, Hypertension.
[104] A. Hagège,et al. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma , 2013, Heart.
[105] A. Pessina,et al. Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy With Treatment of Primary Aldosteronism , 2013, Hypertension.
[106] N. Brown. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis , 2013, Nature Reviews Nephrology.
[107] E. Horváth-Puhó,et al. Multisystem morbidity and mortality in Cushing's syndrome: a cohort study. , 2013, The Journal of clinical endocrinology and metabolism.
[108] J. Borén,et al. A mouse model reveals an important role for catecholamine‐induced lipotoxicity in the pathogenesis of stress‐induced cardiomyopathy , 2013, European journal of heart failure.
[109] J. Toth,et al. Altered hemodynamics, endothelial function, and protein expression occur with aortic coarctation and persist after repair. , 2012, American journal of physiology. Heart and circulatory physiology.
[110] J. Connell,et al. Demonstration of Blood Pressure-Independent Noninfarct Myocardial Fibrosis in Primary Aldosteronism: A Cardiac Magnetic Resonance Imaging Study , 2012, Circulation. Cardiovascular imaging.
[111] R. Holle,et al. Observational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry , 2012, Hypertension.
[112] M. Allessie,et al. Aldosterone promotes atrial fibrillation. , 2012, European heart journal.
[113] R. Wachter,et al. Impact of obstructive sleep apnoea on diastolic function , 2012, European Respiratory Journal.
[114] Yen-Hung Lin,et al. Contrast‐enhanced MRI index of diffuse myocardial fibrosis is increased in primary aldosteronism , 2012, Journal of magnetic resonance imaging : JMRI.
[115] T. Zelinka,et al. High Incidence of Cardiovascular Complications in Pheochromocytoma , 2012, Hormone and Metabolic Research.
[116] N. Madias,et al. Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[117] G. Parati,et al. Clinical relevance of cardiac structure and function abnormalities in patients with Cushing’s syndrome before and after cure , 2012, Clinical endocrinology.
[118] Jeroen J. Bax,et al. Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome. , 2012, European journal of endocrinology.
[119] F. Messerli,et al. Takotsubo-like cardiomyopathy in pheochromocytoma. , 2011, International journal of cardiology.
[120] P. Dabadghao,et al. Cardiovascular dysfunction and catecholamine cardiomyopathy in pheochromocytoma patients and their reversal following surgical cure: results of a prospective case-control study. , 2011, Surgery.
[121] Mark E. Anderson,et al. Oxidation of CaMKII determines the cardiotoxic effects of aldosterone , 2011, Nature Medicine.
[122] J. Lenders,et al. Cardiovascular manifestations of phaeochromocytoma , 2011, Journal of hypertension.
[123] H. Makani,et al. Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome. , 2011, European heart journal.
[124] P. Jones,et al. Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. , 2011, The Journal of clinical endocrinology and metabolism.
[125] G. de Simone,et al. Does Information on Systolic and Diastolic Function Improve Prediction of a Cardiovascular Event by Left Ventricular Hypertrophy in Arterial Hypertension? , 2010, Hypertension.
[126] Alberto Fernández,et al. Prevalence of pituitary adenomas: a community‐based, cross‐sectional study in Banbury (Oxfordshire, UK) , 2010, Clinical endocrinology.
[127] Jeroen J. Bax,et al. Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome. , 2010, European journal of endocrinology.
[128] A. Mihailidou,et al. Glucocorticoids Activate Cardiac Mineralocorticoid Receptors During Experimental Myocardial Infarction , 2009, Hypertension.
[129] N. Dhalla,et al. Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease. , 2009, Canadian journal of physiology and pharmacology.
[130] W. Mali,et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. , 2009, Annals of internal medicine.
[131] A. Verbeek,et al. Metastases but not cardiovascular mortality reduces life expectancy following surgical resection of apparently benign pheochromocytoma. , 2008, Endocrine-related cancer.
[132] D. Rizzoni,et al. Inappropriate Left Ventricular Mass in Patients With Primary Aldosteronism , 2008, Hypertension.
[133] H. Matsubara,et al. Aldosterone Nongenomically Produces NADPH Oxidase–Dependent Reactive Oxygen Species and Induces Myocyte Apoptosis , 2008, Hypertension Research.
[134] É. Mousseaux,et al. Increased central aortic stiffness and left ventricular mass in normotensive young subjects after successful coarctation repair. , 2006, American heart journal.
[135] L. Sechi,et al. Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary Aldosteronism , 2007, Hypertension.
[136] T. Opthof,et al. Aldosterone modulates If current through gene expression in cultured neonatal rat ventricular myocytes , 2007 .
[137] Masayoshi Shichiri,et al. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system. , 2007, Endocrinology.
[138] J. Loscalzo,et al. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity , 2007, Nature Medicine.
[139] M. Iida,et al. Role of aldosterone in left ventricular hypertrophy in hypertension. , 2006, American journal of hypertension.
[140] R. Foley,et al. Left ventricular morphology and function in patients with atherosclerotic renovascular disease. , 2005, Journal of the American Society of Nephrology : JASN.
[141] R. Foley,et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. , 2005, Kidney international.
[142] B. Lorell,et al. Aldosterone directly stimulates cardiac myocyte hypertrophy. , 2004, Journal of cardiac failure.
[143] Phalla Ou,et al. Late systemic hypertension and aortic arch geometry after successful repair of coarctation of the aorta. , 2004, European heart journal.
[144] R. Coleman,et al. Aldosterone Administration to Mice Stimulates Macrophage NADPH Oxidase and Increases Atherosclerosis Development: A Possible Role for Angiotensin-Converting Enzyme and the Receptors or Angiotensin II and Aldosterone , 2004, Circulation.
[145] M. Omura,et al. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.
[146] Jeroen J. Bax,et al. Increased prevalence of regurgitant valvular heart disease in acromegaly. , 2004, The Journal of clinical endocrinology and metabolism.
[147] M. Muiesan,et al. Left ventricular structural and functional characteristics in Cushing's syndrome. , 2003, Journal of the American College of Cardiology.
[148] J. Delyani,et al. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. , 2002, Endocrinology.
[149] D. Celermajer,et al. Survivors of coarctation repair: fixed but not cured , 2002, Heart.
[150] Ricardo Rocha,et al. Aldosterone induces a vascular inflammatory phenotype in the rat heart. , 2002, American journal of physiology. Heart and circulatory physiology.
[151] J. Steinberger,et al. Long-term follow-up of patients after coarctation of the aorta repair. , 2002, The American journal of cardiology.
[152] D. Sawyer,et al. Adrenergic regulation of cardiac myocyte apoptosis , 2001, Journal of cellular physiology.
[153] T. Ino,et al. Restenosis after balloon angioplasty of coarctation: Relationship with ductus arteriosus , 2000, Pediatrics international : official journal of the Japan Pediatric Society.
[154] H. Rennke,et al. Printed in U.S.A. Copyright © 2000 by The Endocrine Society Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy* , 2022 .
[155] B. Biondi,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Cardiovascular Effects of Short-Term Growth Hormone , 2022 .
[156] C. Stier,et al. Downloaded from http://hyper.ahajournals.org / by guest on February 21, 2013Role of Aldosterone in Renal Vascular Injury in Stroke-Prone Hypertensive Rats , 2022 .
[157] E. Porteri,et al. Relations between cardiac and vascular structure in patients with primary and secondary hypertension. , 1998, Journal of the American College of Cardiology.
[158] C. Stier,et al. Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. , 1998, Hypertension.
[159] H. Gardiner,et al. Arterial reactivity is significantly impaired in normotensive young adults after successful repair of aortic coarctation in childhood. , 1994, Circulation.
[160] G. Chatellier,et al. Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma, and pheochromocytoma. , 1993, American journal of hypertension.
[161] K. Weber,et al. Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. , 1993, The American journal of cardiology.
[162] K. Weber,et al. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. , 1992, The Journal of laboratory and clinical medicine.
[163] R. Erbel,et al. Arrhythmia profile in acromegaly. , 1992, European heart journal.
[164] V. Fuster,et al. Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. , 1989, Circulation.
[165] J. Sehested,et al. Different reactivity and structure of the prestenotic and poststenotic aorta in human coarctation. Implications for baroreceptor function. , 1982, Circulation.